Search Tag: Breast cancer imaging
2025 27 Nov
Radiology is under pressure: rising imaging volumes, workforce shortages and increasing complexity in breast cancer care are forcing providers to rethink how work gets done. To address this challenge, Affidea, in collaboration with Biotronics3D and b-rayZ have joined forces to deliver an integrated mammography AI solution inside a PACS/RIS...Read more
2025 15 Aug
Breast carcinoma remains the most common malignant tumour in women worldwide. A key factor in its progression is angiogenesis, the formation of new blood vessels that support tumour growth and metastasis. The microvasculature provides essential information for distinguishing malignant from benign breast lesions, as malignant lesions often display...Read more
2025 15 Aug
Breast carcinoma remains the most common malignant tumour in women worldwide. A key factor in its progression is angiogenesis, the formation of new blood vessels that support tumour growth and metastasis. The microvasculature provides essential information for distinguishing malignant from benign breast lesions, as malignant lesions often display...Read more
2025 15 Aug
Breast carcinoma remains the most common malignant tumour in women worldwide. A key factor in its progression is angiogenesis, the formation of new blood vessels that support tumour growth and metastasis. The microvasculature provides essential information for distinguishing malignant from benign breast lesions, as malignant lesions often display...Read more
2025 01 Apr
Accurate preoperative estimation of tumour size is vital in the management of breast cancer, particularly when the lesion presents as an architectural distortion (AD). These distortions, defined as abnormal arrangements of breast tissue without a definite mass, can represent both benign and malignant processes. Determining the precise extent of invasive...Read more
2024 20 Oct
Breast cancer diagnosis and monitoring have long relied on advanced imaging techniques, with magnetic resonance imaging (MRI) playing a critical role. One such technique, diffusion-weighted imaging (DWI), has shown great promise in enhancing breast cancer detection, staging, and monitoring by measuring the diffusion of water molecules in tissues....Read more
2024 07 Oct
Breast cancer remains one of the leading causes of cancer-related mortality among women. Accurate classification of breast cancer subtypes, based on molecular biomarkers such as oestrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), is critical for guiding treatment decisions and predicting outcomes....Read more
2024 07 Oct
Breast cancer remains one of the leading causes of cancer-related mortality among women. Accurate classification of breast cancer subtypes, based on molecular biomarkers such as oestrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), is critical for guiding treatment decisions and predicting outcomes....Read more